Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CAR-T Therapy Complications”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 0 results

Early research (Phase 1)Active Not RecruitingNCT06544330
What this trial is testing

SYNCAR-001 + STK-009 Without Conditioning Chemotherapy (Lymphodepletion) in Subjects With Severe, Refractory Systemic Autoimmune Rheumatic Disease

Who this might be right for
Systemic Lupus ErythematosusLupus NephritisSystemic Sclerosis
Synthekine 48
Early research (Phase 1)Looking for participantsNCT06469281
What this trial is testing

Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers

Who this might be right for
Epithelial Ovarian CancerPrimary Peritoneal CarcinomaFallopian Tube Cancer
Regeneron Pharmaceuticals 90
Early research (Phase 1)WithdrawnNCT06429800
What this trial is testing

Evaluate the Safety and Preliminary Efficacy of ATA3219 in Participants With Systemic Lupus Erythematosus

Who this might be right for
Lupus NephritisSystemic Lupus Erythematosus
Atara Biotherapeutics
Testing effectiveness (Phase 2)UnknownNCT03916679
What this trial is testing

MESO-CAR T Cells Therapy for Relapsed and Refractory Epithelial Ovarian Cancer

Who this might be right for
Ovarian Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 20
Very early researchUnknownNCT05085418
What this trial is testing

CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Immune Nephritis

Who this might be right for
Immune NephritisAutoimmune DiseasesLupus Nephritis
Zhejiang University 9
Testing effectiveness (Phase 2)WithdrawnNCT06935474
What this trial is testing

C-CAR168 CAR T Cell Therapy for Refractory Autoimmune Disease

Who this might be right for
Lupus Nephritis (LN)
AbelZeta Inc.
Early research (Phase 1)Study completedNCT00019136
What this trial is testing

Gene Therapy and Biological Therapy in Treating Patients With Ovarian Epithelial Cancer

Who this might be right for
Ovarian Cancer
National Cancer Institute (NCI)
Early research (Phase 1)Looking for participantsNCT07297667
What this trial is testing

GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours

Who this might be right for
Alveolar Soft Part SarcomaRenal Cell CarcinomaTriple Negative Breast Cancer
Canadian Cancer Trials Group 30